NIPH Clinical Trials Search

Basic Information

Recruitment status	completed
Health condition(s) or Problem(s) studied
Date of first enrollment	16/11/2015
Target sample size	50
Countries of recruitment	Japan
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : INN of investigational material : mogamulizumab Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : Generic name etc : INN of investigational material : Cyclophosphamide Therapeutic category code : 421 Alkylating agents Dosage and Administration for Investigational material : Generic name etc : INN of investigational material : Doxorubicin Therapeutic category code : 423 Antitumor antibiotics and preparations Dosage and Administration for Investigational material : Generic name etc : INN of investigational material : Vincristine Therapeutic category code : 424 Antineoplastic preparations extracted from plants Dosage and Administration for Investigational material : Generic name etc : INN of investigational material : Prednisolone Therapeutic category code : 245 Adrenal hormone preparations Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcome	safety efficacy
Secondary Outcome	safety efficacy

Key inclusion & exclusion criteria

Age minimum	>= 56age old
Age maximum	Not applicable
Gender	Both
Include criteria
Exclude criteria